2021 ICD-10-CM Code H02.883

Meibomian gland dysfunction of right eye, unspecified eyelid

Version 2021

Valid for Submission

H02.883 is a billable diagnosis code used to specify a medical diagnosis of meibomian gland dysfunction of right eye, unspecified eyelid. The code H02.883 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

Unspecified diagnosis codes like H02.883 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

ICD-10:H02.883
Short Description:Meibomian gland dysfunction of right eye, unspecified eyelid
Long Description:Meibomian gland dysfunction of right eye, unspecified eyelid

Code Classification

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code H02.883 are found in the index:

Replacement Code

H02883 replaces the following previously assigned ICD-10 code(s):

Information for Patients


Eyelid Disorders

Your eyelids help protect your eyes. When you blink, your eyelids spread moisture over your eyes. Blinking also helps move dirt or other particles off the surface of the eye. You close your eyelids when you see something coming toward your eyes. This can help protect against injuries.

Like most other parts of your body, your eyelids can get infected, inflamed, or even develop cancer. There are also specific eyelid problems, including

Treatment of eyelid problems depends on the cause.


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019